OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

• Status: Completed
• Trial end date: 2005-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the safety and perform preliminary clinical evaluation in patients with mild to moderate CDAD.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Optimer Pharmaceuticals LLC

Criteria

Inclusion Criteria:

• Patients with CDAD

Exclusion Criteria:

• Patients with severe CDAD